VAN Voorhees Seth
SEC-identified person · CIK 1284934 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| NRX Pharmaceuticals, Inc. NRXP | Chief Financial Officer | filed 2022–2022 |
| PDS Biotechnology Corp PDSB | Chief Financial Officer | filed 2021–2021 |
| Research Frontiers INC REFR | VicePresident-Business Dev/CFO | filed 2011–2020 |
| American Pacific Corp APFC | VP, CFO & Treasurer | filed 2006–2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.